Evaluation of Healthcare Resource Utilization and Costs Among Patients with Chronic Myeloid Leukemia after Disease Progression

被引：0
作者：
Jabbour, Elias [1 ]
Lin, Jay [2 ]
Siegartel, Lisa R. [3 ]
Lingohr-Smith, Melissa [2 ]
Menges, Brandy [2 ]
Makenbaeva, Dinara [3 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
[2] Novosys Hlth, Green Brook, NJ USA
[3] Bristol Myers Squibb, Plainsboro, NJ 08536 USA
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.3573.3573
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3573
引用
收藏
页数：5
相关论文
共 50 条
  • [31] Health Care Utilization and Costs Among Patients with Chronic Myeloid Leukemia Using Tyrosine Kinase Inhibitors
    Huang, Joanna C.
    Karve, Sudeep
    Porwal, Sanchita
    Thakkar, Kushan
    Marshall, Thomas
    Rosenberg, Tanja
    [J]. BLOOD, 2018, 132
  • [32] Treatment Patterns, Healthcare Resource Utilization, and Costs of Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma in the US
    Yang, Xiaoqin
    Zanardo, Enrico
    Lejeune, Dominique
    De Nigris, Enrico
    Sarpong, Eric
    Farooqui, Mohammed
    Laliberte, Francois
    [J]. ONCOLOGIST, 2024, 29 (03) : E360 - E371
  • [33] Healthcare resource utilization and treatment costs of Finnish chronic inflammatory bowel disease patients treated with infliximab*
    Ylisaukko-Oja, Tero
    Torvinen, Saku
    Ventola, Hanna
    Schmidt, Saku
    Herrala, Sauli
    Kononoff, Jenni
    Voutilainen, Markku
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2019, 54 (06) : 726 - 732
  • [34] Impact of secondary hyperparathyroidism on disease progression, healthcare resource utilization and costs in pre-dialysis CKD patients
    Schumock, Glen T.
    Andress, Dennis
    Marx, Steven E.
    Sterz, Raimund
    Joyce, Amie T.
    Kalantar-Zadeh, Kamyar
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (11) : 3037 - 3048
  • [35] Real World Treatment Patterns, Adverse Events and Healthcare Resource Utilization and Costs Among Chronic Lymphocytic Leukemia (CLL) Patients in the United States
    Kabadi, Shaum
    Le, Lisa
    Byfield, Stacey Dacosta
    Olufade, Temitope O.
    [J]. BLOOD, 2018, 132
  • [36] Healthcare Resource Utilization and Costs Among Patients With Stroke -related Spasticity Before and After Treatment With OnabotulinumtoxinA
    Bloudek, Lisa
    Migliaccio-Walle, Kristen
    Oliveri, David
    Tung, Amy
    Gillard, Patrick
    [J]. NEUROLOGY, 2022, 98 (18)
  • [37] Real-World Treatment Patterns, Healthcare Resource Utilization, and Costs in Patients with Newly Diagnosed Acute Myeloid Leukemia (AML)
    Stein, Eytan M.
    Latremouille-Viau, Dominick
    Guerin, Annie
    Shi, Sherry
    Gagnon-Sanschagrin, Patrick
    Bonifacio, Gaetano
    Joseph, George J.
    [J]. BLOOD, 2016, 128 (22)
  • [38] THE IMPACT OF HYPERKALEMIA ON SURVIVAL AND HEALTHCARE RESOURCE UTILIZATION AMONG PATIENTS WITH CHRONIC KIDNEY DISEASE IN CHINA
    Zhang, J.
    He, X.
    Wu, J.
    [J]. VALUE IN HEALTH, 2021, 24 : S237 - S238
  • [39] Healthcare Resource Utilization and Costs of Relapsed or Refractory Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Treated with Ibrutinib
    Yang, Xiaoqin
    Zanardo, Enrico
    Lejeune, Dominique
    De Nigris, Enrico
    Sarpong, Eric
    Farooqui, Mohammed Z. H.
    Laliberte, Francois
    [J]. BLOOD, 2022, 140 : 10911 - 10912
  • [40] Healthcare resource utilization and costs of chronic lymphocytic leukemia/small lymphocytic lymphoma patients who relapse or are refractory to ibrutinib
    De Nigris, Enrico
    Yang, Xiaoqin
    Zanardo, Enrico
    Lejeune, Dominique
    Farooqui, Mohammed Z. H.
    Gandra, Shravanthi R.
    Laliberte, Francois
    [J]. FUTURE ONCOLOGY, 2024, 20 (35) : 2723 - 2735
12345